Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
David M Dorfman
Affiliation
Brigham and Women's Hospital and Harvard Medical School
ORCID
Career Start Year
1982
Papers
187
H Index
51
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37683132
Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing.
JCO Oncol Pract
2024
37776247
PCNEO, a New Proficiency Testing Program for Flow Cytometric Analysis of Plasma Cell Neoplasms From the College of American Pathologists Diagnostic Immunology and Flow Cytometry Committee.
Arch Pathol Lab Med
2024
36533670
Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia.
Int J Cancer
2023
36752202
Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma.
JCI Insight
2023
36737429
Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics.
Blood Cancer J
2023
35082402
Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma.
Leukemia
2022
35614537
AML with t(8;16) mimicking acute promyelocytic leukaemia.
Int J Lab Hematol
2022
35496359
Non-Hodgkin lymphoma mimicking acute leukemia: a report of six cases and review of the literature.
J Hematop
2022
35513704
Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma.
Leukemia
2022
35064930
A case of peripheral T-cell lymphoma, NOS, mimicking acute monocytic leukemia.
Am J Hematol
2022
32886757
Participation in the College of American Pathologists Laboratory Accreditation Program Decreases Variability in B-Lymphoblastic Leukemia and Plasma Cell Myeloma Flow Cytometric Minimal Residual Disease Testing: A Follow-up Survey.
Arch Pathol Lab Med
2021
33751108
miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms.
Blood
2021
34581772
Impact of sickle cell trait on morbidity and mortality from SARS-CoV-2 infection.
Blood Adv
2021
33219376
Laboratory Workup of Lymphoma in Adults.
Am J Clin Pathol
2021
33175094
Laboratory Workup of Lymphoma in Adults: Guideline From the American Society for Clinical Pathology and the College of American Pathologists.
Arch Pathol Lab Med
2021
32241847
A case of Epstein Barr virus-related post-transplant lymphoproliferative disorder after haploidentical allogeneic stem cell transplantation using post-transplantation cyclophosphamide.
Haematologica
2020
30431665
Acute myeloid leukemia with minimal differentiation (AML M0) mimicking acute lymphoblastic leukemia.
Am J Hematol
2019
31530176
Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy.
Clin Appl Thromb Hemost
2019
31326977
Highly differentiated cytotoxic T cells in inclusion body myositis.
Brain
2019
30715093
Utility of a Simple and Robust Flow Cytometry Assay for Rapid Clonality Testing in Mature Peripheral T-Cell Lymphomas.
Am J Clin Pathol
2019
31004444
Pleomorphic mantle cell lymphoma mimicking diffuse large B-cell lymphoma in peripheral blood and bone marrow.
Am J Hematol
2019
30854558
Use of a Blast Dominance-Hematogone Index for the Flow Cytometric Evaluation of Myelodysplastic Syndrome (MDS).
Am J Clin Pathol
2019
30911135
Highly efficient therapeutic gene editing of human hematopoietic stem cells.
Nat Med
2019
30371509
Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.
Am J Surg Pathol
2019
27305702
Lupus anticoagulant testing using two parallel methods detects additional cases and predicts persistent positivity.
Clin Chem Lab Med
2018
30043450
Highly atypical myeloblasts in acute myeloid leukaemia with myelodysplasia-related changes in a patient with short telomere syndrome.
Br J Haematol
2018
29789628
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models.
Nat Commun
2018
29794078
Leukemic-phase progression of aleukemic mast cell leukemia.
Blood
2018
29327713
Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling.
Mod Pathol
2018
28850707
Ectopic Intrathyroidal Thymic Tissue Mimicking Thyroid Nodules in Children.
J Ultrasound Med
2018
27919167
An unusual case of chronic lymphocytic leukemia/small lymphocytic lymphoma with nodular morphology.
Leuk Lymphoma
2017
28314380
Myocardial Induction of Type 3 Deiodinase in Dilated Cardiomyopathy.
Thyroid
2017
29128079
Clinical Flow Cytometry: State-of-the-Art and New Approaches.
Clin Lab Med
2017
29128073
Mast Cell Disease Assessment by Flow Cytometric Analysis.
Clin Lab Med
2017
29128066
Flow Cytometry of TÂ cells and T-cell Neoplasms.
Clin Lab Med
2017
29048129
Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma.
Br J Haematol
2017
28551327
T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiation.
Hum Pathol
2017
28575142
Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders.
Am J Clin Pathol
2017
26920676
Association of inclusion body myositis with T cell large granular lymphocytic leukaemia.
Brain
2016
27764795
A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications.
Oncotarget
2016
27479652
FLOCK cluster analysis of plasma cell flow cytometry data predicts bone marrow involvement by plasma cell neoplasia.
Leuk Res
2016
27479034
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.
Cancer Cell
2016
27578265
Flow Cytometry of Nonhematopoietic Neoplasms.
Acta Cytol
2016
27282353
Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas.
Mod Pathol
2016
26834126
Automated Nucleated RBC Measurement Using the Sysmex XE-5000 Hematology Analyzer: Frequency and Clinical Significance of the Nucleated RBCs.
Am J Clin Pathol
2016
27070704
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.
Cancer Cell
2016
25012943
Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphoma.
Leuk Lymphoma
2015
26486741
FLOCK cluster analysis of mast cell event clustering by high-sensitivity flow cytometry predicts systemic mastocytosis.
Am J Clin Pathol
2015
26320100
EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
Blood
2015
27148573
Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case.
Cold Spring Harb Mol Case Stud
2015
1 - 50 of 187
Column Actions
Search
Recommended Authors
Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year
2013
Number of shared co-authors
1
Xiaoqiong Wang
The University of Texas MD Anderson Cancer Center
Career Start Year
2011
Number of shared co-authors
0
Alexa J Siddon
Yale School of Medicine
Career Start Year
2010
Number of shared co-authors
0
David Wu
University of Washington
Career Start Year
2010
Number of shared co-authors
1
Jennifer Dunlap
Oregon Health & Science University
Career Start Year
2008
Number of shared co-authors
0
Alexandra E Kovach
Children's Hospital of Los Angeles
Career Start Year
2008
Number of shared co-authors
3
Jeremy C Wallentine
Intermountain Medical Center
Career Start Year
2007
Number of shared co-authors
0
Melissa H Cessna
Intermountain Medical Center
Career Start Year
2001
Number of shared co-authors
0
Robin D LeGallo
University of Virginia Department of Pathology
Career Start Year
2001
Number of shared co-authors
0
Guang Fan
Oregon Health and Science University
Career Start Year
2000
Number of shared co-authors
1
Gyeongsin Park
Seoul St. Mary's Hospital, The Catholic University of Korea
Career Start Year
1999
Number of shared co-authors
0
Sze Fai Yip
Tuen Mun Hospital
Career Start Year
1999
Number of shared co-authors
0
Travis J Hollmann
Memorial Sloan Kettering Cancer Center
Career Start Year
1998
Number of shared co-authors
3
Eric Tse
School of Clinical Medicine, University of Hong Kong
Career Start Year
1997
Number of shared co-authors
0
Francisco Vega
The University of Texas MD Anderson Cancer Center
Career Start Year
1996
Number of shared co-authors
8
Kelly Bethel
Scripps Clinic Medical Group
Career Start Year
1995
Number of shared co-authors
0
Christopher D Gocke
Johns Hopkins University School of Medicine
Career Start Year
1992
Number of shared co-authors
1
Kikkeri N Naresh
Fred Hutchinson Cancer Research Center
Career Start Year
1989
Number of shared co-authors
1
Louis M Staudt
National Cancer Institute, National Institutes of Health
Career Start Year
1983
Number of shared co-authors
6
Sherrie L Perkins
University of Utah
Career Start Year
1982
Number of shared co-authors
2
Elias Campo
Institute for Biomedical Research August Pi I Sunyer
Career Start Year
1981
Number of shared co-authors
3
Maryalice Stetler-Stevenson
National Cancer Institute, National Institutes of Health
Career Start Year
1981
Number of shared co-authors
0
Mark Raffeld
Center for Cancer Research, National Cancer Institute
Career Start Year
1981
Number of shared co-authors
1
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Career Start Year
1979
Number of shared co-authors
0
Stefania Pittaluga
National Cancer Institute, National Institutes of Health
Career Start Year
1979
Number of shared co-authors
2
Dennis B Cornfield
Lehigh Valley Hospital
Career Start Year
1977
Number of shared co-authors
0
Thomas J Kipps
University of California San Diego
Career Start Year
1977
Number of shared co-authors
6
Sanford A Stass
University of Maryland School of Medicine
Career Start Year
1977
Number of shared co-authors
1
Elaine S Jaffe
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
1972
Number of shared co-authors
4
Robin Fo??
Sapienza University.
Career Start Year
1968
Number of shared co-authors
7
row(s) 1 - 30 of 30
Collaborators
Stuart H Orkin
Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers
11
Kenneth C Anderson
Dana Farber Cancer Institute
Co-authored papers
10
Daniel J DeAngelo
Dana-Farber Cancer Institute
Co-authored papers
5
Vinodh Pillai
Co-authored papers
5
David M Weinstock
Merck & Co.
Co-authored papers
5
Donna Neuberg
Co-authored papers
4
Giorgio Inghirami
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Co-authored papers
4
Jack L Pinkus
Brigham and Women's Hospital Department of Neurology, and Harvard Medical School
Co-authored papers
3
Benjamin L Ebert
Co-authored papers
3
Aaron R Thorner
Co-authored papers
3
Jason L Hornick
Brigham and Women's Hospital and Harvard Medical School
Co-authored papers
3
Richard M Stone
Dana Farber Cancer Institute
Co-authored papers
3
David P Steensma
Novartis Institutes for BioMedical Research
Co-authored papers
3
Amanda L Christie
Dana-Farber Cancer Institute
Co-authored papers
3
Mark A Murakami
Dana-Farber Cancer Institute
Co-authored papers
3
Myles Brown
Co-authored papers
2
Jerome Ritz
Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital
Co-authored papers
2
Daniel E Bauer
Co-authored papers
2
Michael J Kluk
Co-authored papers
2
Anthony A Amato
Brigham Women's Hospital, Harvard Medical School
Co-authored papers
2
Steven M Kornblau
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Alex Look
Dana-Farber Cancer Institute
Co-authored papers
2
Timothy A Graubert
Massachusetts General Hospital
Co-authored papers
2
Paul Van Hummelen
Co-authored papers
2
Steven M Greenberg
Massachusetts General Hospital
Co-authored papers
2
Kimberly Stegmaier
Dana-Farber Cancer Institute
Co-authored papers
2
Catherine J Wu
Co-authored papers
1
Sara O Vargas
Boston Children's Hospital
Co-authored papers
1
Bogdan Budnik
Co-authored papers
1
Peter W Marks
Center for Biologics Evaluation and Research
Co-authored papers
1
1 - 30